HER-2 Signaling in Human Breast Cancer

QR Code

HER-2 Signaling in Human Breast Cancer

None

Saved in:

Bibliographic Details
Main Author:	Ignatoski, Kathleen M. Woods
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/23369
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Electronics of HER2/neu Positive Breast Cancer Cells
by: Baumann, Jan, et al.
Published: (2011)

Novel Therapeutic Strategies and Combinations for HER2-Overexpressing Breast Cancer
by: Shabaya, Sylvia, et al.
Published: (2011)

Targeting HER-2 Signaling Network: Implication in Radiation Response
by: Kim, In Ah
Published: (2011)

Human Epidermal Growth Factor (Her) in Gastric Cancer
by: Czyzewska, Jolanta
Published: (2011)

Targeting EGFR and HER2 for Molecular Imaging of Cancer
by: Gong, Haibiao, et al.
Published: (2012)

Dysregulation of Wnt Signaling in Breast Cancer
by: King, Taj D., et al.
Published: (2011)

Potential Signaling Pathways Activated in Cancer Stem Cells in Breast Cancer
by: Gotoh, Noriko
Published: (2011)

Signal Transduction Pathways in Breast Cancer – Drug Targets and Challenges
by: Azab, Samar, et al.
Published: (2011)

ErbB2/HER2: Its Contribution to Basic Cancer Biology and the Development of Molecular Targeted Therapy
by: Yamamoto, Tadashi, et al.
Published: (2011)

Immunomorphological specifcity of HER2-low breast cancer
by: I. V. Mikhailov, et al.
Published: (2024-11-01)

EGFR-Ligand Signaling in Breast Cancer Metastasis: Recurring Developmental Themes
by: Nickerson, Nicole K., et al.
Published: (2011)

Progestogens and Breast Cancer Risk – In Vitro Investigations with Human Benign and Malignant Epithelial Breast Cells
by: Mueck, Alfred O., et al.
Published: (2011)

STUDY OF THE EFFECT OF LOMUSTIN ON HER2-POSITIVE BREAST CANCER IN FVB/N HER-2 TRANSGENIC MICE
by: A. N. Stukov, et al.
Published: (2019-11-01)

Signal Transduction Pathways Mediated by Unsaturated Free Fatty Acids in Breast Cancer Cells
by: Salazar, Eduardo Perez, et al.
Published: (2011)

POSSIBILITIES OF THERAPY OF HER-2-POSITIVE REGIONAL BREAST CANCER
by: A. S. Belokhvostova, et al.
Published: (2015-04-01)

Present and future of breast cancer anti-Her-2-therapy
by: V. P. Letyagin
Published: (2014-07-01)

Target therapy in treatment of HER2-positive breast cancer
by: A. S. Belokhvostova, et al.
Published: (2016-02-01)

Calcium, Ca2+-Sensing Receptor and Breast Cancer
by: Huang, Chunfa, et al.
Published: (2011)

Treatment of luminal HER2-negative breast cancer: opinion of experts
by: E. V. Artemeva, et al.
Published: (2024-06-01)

Improving treatment outcomes for patients with HER2‑positive breast cancer using neoadjuvant double HER2 blockade
by: V. F. Semiglazov, et al.
Published: (2024-11-01)

Capivasertib/Fulvestrant in patients with HR+, HER2-low or HER2-negative locally advanced or metastatic breast cancer
by: Karam Aboud, et al.
Published: (2025-07-01)

Efficacy and Safety of HER2-Targeted Agents for Breast Cancer with HER2-Overexpression: A Network Meta-Analysis.
by: Qiuyan Yu, et al.
Published: (2015-01-01)

Fibrillar Human Serum Albumin Suppresses Breast Cancer Cell Growth and Metastasis
by: Hung, Shao-Wen, et al.
Published: (2011)

The Role of MicroRNAs in Estrogen Receptor α-Positive Human Breast Cancer
by: Yamashita, Hiroko, et al.
Published: (2011)

ER-Alpha36 Mediates Non-Genomic Estrogen and Anti-Estrogen Signaling in Breast Cancer Cells
by: Wang, ZhaoYi, et al.
Published: (2011)

Beyond HER2-Positive: The ADC Revolution in Breast Cancer Care
by: Marucs Vetter
Published: (2025-06-01)

HER-2-positive metastatic breast cancer: new possibilities for therapy
by: E. V. Artamonova, et al.
Published: (2014-07-01)

1,25(OH)2D3 and Cyclooxygenase-2: Possible Targets for Breast Cancer?
by: Thill, M., et al.
Published: (2011)

Pathologic Response and Survival Outcomes on HER2-Low vs. HER2-Zero in Breast Cancer Receiving Neoadjuvant Chemotherapy
by: Rumeysa Colak, et al.
Published: (2025-06-01)

Epigenetics and Breast Cancer
by: Alokail, Majed Saleh
Published: (2011)

Scleroderma and Breast Cancer
by: Michalinos, Adamantios, et al.
Published: (2011)

Current approaches to the treatment of HER2‑positive breast cancer with brain metastases
by: T. Yu. Semiglazova, et al.
Published: (2021-06-01)

CLINICAL CHARACTERISTICS OF BREAST CANCER WITH STEROID RECEPTORS EXPRESSION AND HER2 AMPLIFICATION
by: F. V. Moiseenko, et al.
Published: (2017-02-01)

EXPERIENCE OF USING PERTUZUMAB IN ANTICANCER THERAPY FOR HER2-POSITIVE BREAST CANCER
by: O. I. Kit, et al.
Published: (2021-05-01)

Oncogenic Signaling in Gastric Cancer
by: Santos-Silva, Filipe
Published: (2011)

Signaling Pathways in Liver Cancer
by: Wu, Xinle, et al.
Published: (2012)

Fourth Swiss Annual Meeting on HER2-Positive Breast Cancer: Antibody-Drug Conjugates in HER2-Positive Disease and Beyond
by: Marcus Vetter, et al.
Published: (2025-06-01)

Clinical Outcomes of CDK4/6 Inhibitor Therapy in HR+/HER2− Metastatic Breast Cancer: A Multicenter Comparison of HER2-Low and HER2-Zero Subgroups
by: Erkan Ozcan, et al.
Published: (2025-01-01)

Interactions of STAP-2 with BRK and STAT3/5 in Breast Cancer Cells
by: Ikeda, Osamu, et al.
Published: (2011)

Silver Jubilee of HER2 targeting: a clinical success in breast cancer
by: Jianli Zhao, et al.
Published: (2025-08-01)